Tag: CD276 (B7-H3) CAR-T therapy

Home / CD276 (B7-H3) CAR-T therapy

Categories

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

CAR T-Cell treatment Chimeric Antigen Receptor (CAR) T-cell treatments, which target antigens that are unique to cancer, have shown amazing results in curing leukemia and lymphoma that has not respon...
cd276-b7-h3-car-t-therapy

Scan the code